Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEFINITY vs saline contrast-enhanced ultrasound for focal liver lesions
CTR20170973Phase 3Completed
- Sponsor
- Lansource Medical Imaging
- Start
- Sep 2017
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perflutren lipid microspheres in focal liver lesion, sponsored by Lansource Medical Imaging. Started Sep 2017; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
focal liver lesion
Beyond the preview
Go deeper on CTR20170973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170973.